Frontiers in Molecular Medicine

Volume 5 - 2025

Mini Review

Published on 26 Jun 2025

Potential role of N6-methyladenosine modification in circular RNA biogenesis and function in the inflammatory responses

Heedoo Lee
Leo Chen
Yang Jin

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1607661

293 views

Review

Published on 19 Jun 2025

Neural stem cells in adult neurogenesis and their therapeutic applications in neurodegenerative disorders: a concise review

Teketay Bayleyegn Derso
Bemrew Admassu Mengistu
Yitayew Demessie
Melkie Dagnaw Fenta
Kalkidan Getnet

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1569717

1,212 views

Editorial

Published on 02 Jun 2025

Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells

Kishor Pant
Mark C. Glassy

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1633469

752 views

Editorial

Published on 16 May 2025

Editorial: Epigenetics and stem cell therapy in cancer and diseases

Sonia Coni
Roberto Schirano
Camilla Manfredi
Paola Infante
Veronica Veschi

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1621093

803 views

Review

Published on 20 Feb 2025

Cell surface vimentin: a natural human immune response target for immunotherapy

Mark C. Glassy

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1552323

1,234 views

Editorial

Published on 18 Feb 2025

Editorial: Tuberculosis: host immunity, diagnostics and therapeutics

Anthony G. Tsolaki
Amy K. Barczak
Uday Kishore

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1568256

880 views

Review

Published on 13 Feb 2025

Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis

D. Y. Mengistu
M. Terribili
C. Pellacani
L. Ciapponi
M. Marzullo

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1530719

3,023 views
1 citation

Editorial

Published on 11 Feb 2025

Editorial: Neuroinflammatory aspects in neurological disorders

Pinto Alipio
Loidl C. Fabián
Goldstein Jorge

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2025.1557546

873 views

Volume 4 - 2024

Editorial

Published on 09 Jan 2025

Editorial: Gene therapy and genome editing for metabolic liver disorders

Fanny Collaud
Giulia Bortolussi

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1543685

887 views

Brief Research Report

Published on 08 Jan 2025

An artificial transcription factor that activates potent interferon-γ expression in human Jurkat T Cells

Ashley King
Davis Noblitt
Olivia Sherron
Clara Kjerfve
Lydia Pless
Nicholas L. Truex

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1492370

2,377 views

Original Research

Published on 06 Jan 2025

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model

Caroline Schoenherr
Stefan Pietzsch
Cristina Barca
Franziska E. Müller
Frauke S. Bahr
Martina Kasten
Andre Zeug
Sergej Erschow
Christine S. Falk
Evgeni Ponimaskin

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1487526

1,794 views

Opinion

Published on 27 Nov 2024

Human-specific gene ARHGAP11B—potentially an additional tool in the treatment of neurodegenerative diseases?

Wieland B. Huttner

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1465647

944 views

Hypothesis and Theory

Published on 18 Sep 2024

DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome

Grace Haroun
Erlinda M. Gordon

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1461151

1,615 views
1 citation

Review

Published on 06 Sep 2024

Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy

Armel Hervé Nwabo Kamdje
Hervet Paulain Dongmo Fogang
Patrice N. Mimche

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1426454

3,072 views
3 citations

Editorial

Published on 03 Jul 2024

Editorial: Mitochondrial dysfunction affects mechano-energetic coupling in heart failure

Jan Dudek
Julia Ritterhoff

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1433102

1,215 views

Original Research

Published on 29 Apr 2024

Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy

Malte Hachmann
Güntas Gülcan
Ranjithkumar Rajendran
Marcus Höring
Gerhard Liebisch
Akash Bachhuka
Michael Kohlhaas
Christoph Maack
Süleyman Ergün
Jan Dudek

Frontiers in Molecular Medicine

doi 10.3389/fmmed.2024.1389456

3,173 views
2 citations